These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23925092)

  • 1. [Risk factors for atherosclerotic disease from the Japanese Elderly Diabetes Intervention Trial (J-EDIT)].
    Araki A
    Nihon Ronen Igakkai Zasshi; 2013; 50(1):53-5. PubMed ID: 23925092
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type 2 diabetes mellitus beyond traditional risk factors: the Japanese Elderly Diabetes Intervention Trial.
    Iijima K; Iimuro S; Shinozaki T; Ohashi Y; Sakurai T; Umegaki H; Araki A; Ouchi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():77-87. PubMed ID: 22435943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Japanese Elderly Diabetes Intervention Trial (J-EDIT)].
    Ito H
    Nihon Rinsho; 2006 Jan; 64(1):21-6. PubMed ID: 16408442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T; Matsuyama Y; Iimuro S; Umegaki H; Sakurai T; Araki A; Ohashi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():88-102. PubMed ID: 22435944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lifestyle of elderly patients with diabetes mellitus].
    Fukuoka Y; Yamada Y
    Nihon Rinsho; 2013 Nov; 71(11):1965-9. PubMed ID: 24397167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between obesity and atherosclerotic risk in elderly type 2 diabetic patients].
    Wakabayashi I; Masuda H
    Nihon Ronen Igakkai Zasshi; 2004 Mar; 41(2):223-7. PubMed ID: 15148762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerotic disease in non-insulin-dependent diabetes mellitus: role of abnormal lipids and the place for lipid-altering therapies.
    Orloff DG; Blazing MA; O'Connor CM
    Am Heart J; 1999 Nov; 138(5 Pt 1):S406-12. PubMed ID: 10539805
    [No Abstract]   [Full Text] [Related]  

  • 8. Update: non-insulin-dependent diabetes mellitus.
    Sheehan JP
    Compr Ther; 1990 Jul; 16(7):56-61. PubMed ID: 2208959
    [No Abstract]   [Full Text] [Related]  

  • 9. [General concept and pathophysiological mechanisms of progression of macrovascular complications in diabetes].
    Kashiwagi A
    Nihon Rinsho; 2010 May; 68(5):777-87. PubMed ID: 20446569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism of lipoproteins in diabetes mellitus].
    Joven J; Vilella E; Masana L
    Med Clin (Barc); 1989 Dec; 93(19):752-5. PubMed ID: 2695708
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atherosclerosis in diabetes mellitus].
    Stange EF
    Internist (Berl); 1989 May; 30(5):297-303. PubMed ID: 2661472
    [No Abstract]   [Full Text] [Related]  

  • 12. Lifestyle Change Plus Dental Care (LCDC) program improves knowledge, attitude, and practice (KAP) toward oral health and diabetes mellitus among the elderly with type 2 diabetes.
    Saengtipbovorn S; Taneepanichskul S
    J Med Assoc Thai; 2015 Mar; 98(3):279-90. PubMed ID: 25920299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is macroangiopathy a complication of diabetes mellitus? I.Hyper- insulinemia].
    Goldsztajn P
    Przegl Lek; 1990; 47(7):551-6. PubMed ID: 2284423
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus.
    Pyörälä K; Uusitupa M; Laakso M; Siitonen O; Niskanen L; Rönnemaa T
    Diabete Metab; 1987 Jul; 13(3 Pt 2):345-9. PubMed ID: 3308562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microangiopathic complications in type 2 diabetes].
    Strojek K; Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():45-51. PubMed ID: 9686533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAD. The "vascular" in cardiovascular disease.
    Braunstein JB
    Diabetes Forecast; 2002 Sep; 55(9):46-8. PubMed ID: 14765463
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular mechanism for accelerated atherosclerosis in diabetes and its potential therapeutic intervention.
    Yamagishi S; Nakamura K; Takeuchi M; Imaizumi T
    Int J Clin Pharmacol Res; 2004; 24(4):129-34. PubMed ID: 15754918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperinsulinaemia as a possible risk factor of macrovascular disease in diabetes mellitus. An overview.
    Janka HU; Standl E
    Diabete Metab; 1987 Jul; 13(3 Pt 2):279-83. PubMed ID: 3308556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 20. Lower physical activity, but not excessive calorie intake, is associated with metabolic syndrome in elderly with type 2 diabetes mellitus: the Japanese Elderly Diabetes Intervention Trial.
    Iijima K; Iimuro S; Ohashi Y; Sakurai T; Umegaki H; Araki A; Yoshimura Y; Ouchi Y; Ito H;
    Geriatr Gerontol Int; 2012 Apr; 12 Suppl 1():68-76. PubMed ID: 22435942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.